Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia

Ottmann, Oliver G. ORCID: https://orcid.org/0000-0001-9559-1330, Müller-Tidow, Carsten, Krämer, Alwin, Schlenk, Richard F., Lübbert, Michael, Bug, Gesine, Krug, Utz, Bochtler, Tilmann, Voss, Florian, Taube, Tillmann, Liu, Dan, Garin-Chesa, Pilar and Döhner, Hartmut 2019. Phase I dose-escalation trial investigating volasertib as monotherapy or in combination with cytarabine in patients with relapsed/refractory acute myeloid leukaemia. British Journal of Haematology 184 (6) , pp. 1018-1021. 10.1111/bjh.15204

Preview

PDF - Accepted Post-Print Version Download (484kB) | Preview

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Publisher:	Wiley
ISSN:	0007-1048
Date of First Compliant Deposit:	3 June 2019
Date of Acceptance:	3 June 2018
Last Modified:	27 Nov 2024 07:15
URI:	https://orca.cardiff.ac.uk/id/eprint/123126

Citation Data

Cited 21 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item